RESPONSE TO 2ND LINE CHEMOTHERAPY IN OVARIAN-CANCER OF EPITHELIAL ORIGIN

被引：4

作者：

MENCZER, J

BAITNER, S

MODAN, M

CHAITCHIK, S

BRENNER, H

机构：

[1] TEL AVIV UNIV,CHAIM SHEBA MED CTR,SACKLER SCH MED,DEPT CLIN EPIDEMIOL,TEL HASHOMER,ISRAEL

[2] TEL AVIV UNIV,CHAIM SHEBA MED CTR,SACKLER SCH MED,DEPT ONCOL,TEL HASHOMER,ISRAEL

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1981年 / 17卷 / 12期

关键词：

D O I：

10.1016/0014-2964(81)90005-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1259 / 1262

页数：4

共 15 条

[1] 2ND-LINE EFFICACY OF INTERMEDIATE HIGH-DOSE METHOTREXATE WITH CITROVORUM FACTOR RESCUE + CYCLOPHOSPHAMIDE IN OVARIAN-CANCER [J].

BARLOW, JJ ;

PIVER, MS .

GYNECOLOGIC ONCOLOGY, 1979, 7 (02) :233-238

[2]

BUCKNER HW, 1978, CANCER TREAT REP, V62, P1021

[3]

GRIFFITHS CT, 1979, CANCER TREAT REP, V63, P235

[4]

JOHNSON BL, 1978, CANCER, V42, P2157, DOI 10.1002/1097-0142(197811)42:5<2157::AID-CNCR2820420511>3.0.CO

[5]

2-7

[6]

KARDINAL CG, 1977, CANCER TREAT REP, V61, P1691

[7]

LELE SB, 1978, OBSTET GYNECOL, V51, P101

[8] MELPHALAN VS POLYMELPHALANUM IN OVARIAN CANCER-PATIENTS RESISTANT TO CYCLOPHOSPHAMIDE - TENTATIVE STATISTICAL APPROACH TO BALANCE RISKS AND BENEFITS [J].

MORASCA, L ;

RECCHIA, M ;

GRAMELLINI, E ;

BOLIS, G ;

MANGIONI, C .

EUROPEAN JOURNAL OF CANCER, 1977, 13 (08) :817-820

[9]

OMURA G, 1977, CANCER TREAT REP, V61, P1533

[10] DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES [J].

PETO, R ;

PIKE, MC ;

ARMITAGE, P ;

BRESLOW, NE ;

COX, DR ;

HOWARD, SV ;

MANTEL, N ;

MCPHERSON, K ;

PETO, J ;

SMITH, PG .

BRITISH JOURNAL OF CANCER, 1977, 35 (01) :1-39

← 1 2 →